The Market Reports

Index

1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application: (2021-2027)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Nuclear Medicines Revenue 2016-2027
1.4.2 Global Therapeutic Nuclear Medicines Sales 2016-2027
1.4.3 Therapeutic Nuclear Medicines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Therapeutic Nuclear Medicines Market Competition by Manufacturers
2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites, Area Served, Product Type
2.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.5.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue
2.5.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Therapeutic Nuclear Medicines Retrospective Market Scenario by Region
3.1 Global Therapeutic Nuclear Medicines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Therapeutic Nuclear Medicines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.3.1 North America Therapeutic Nuclear Medicines Sales by Country
3.3.2 North America Therapeutic Nuclear Medicines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.4.1 Europe Therapeutic Nuclear Medicines Sales by Country
3.4.2 Europe Therapeutic Nuclear Medicines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Region
3.5.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region
3.5.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.6.1 Latin America Therapeutic Nuclear Medicines Sales by Country
3.6.2 Latin America Therapeutic Nuclear Medicines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.7.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country
3.7.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Therapeutic Nuclear Medicines Historic Market Analysis by Type
4.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
4.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2021)
4.3 Global Therapeutic Nuclear Medicines Price by Type (2016-2021)

5 Global Therapeutic Nuclear Medicines Historic Market Analysis by Application
5.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
5.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2016-2021)
5.3 Global Therapeutic Nuclear Medicines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Q BioMed
6.4.1 Q BioMed Corporation Information
6.4.2 Q BioMed Description and Business Overview
6.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
6.4.5 Q BioMed Recent Developments/Updates
6.5 Curium Pharmaceuticals
6.5.1 Curium Pharmaceuticals Corporation Information
6.5.2 Curium Pharmaceuticals Description and Business Overview
6.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.5.5 Curium Pharmaceuticals Recent Developments/Updates
6.6 Jubilant DraxImage
6.6.1 Jubilant DraxImage Corporation Information
6.6.2 Jubilant DraxImage Description and Business Overview
6.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
6.6.5 Jubilant DraxImage Recent Developments/Updates
6.7 Dongcheng
6.6.1 Dongcheng Corporation Information
6.6.2 Dongcheng Description and Business Overview
6.6.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
6.7.5 Dongcheng Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Acrotech Biopharma.
6.9.1 Acrotech Biopharma. Corporation Information
6.9.2 Acrotech Biopharma. Description and Business Overview
6.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
6.9.5 Acrotech Biopharma. Recent Developments/Updates
6.10 Progenics Pharmaceuticals
6.10.1 Progenics Pharmaceuticals Corporation Information
6.10.2 Progenics Pharmaceuticals Description and Business Overview
6.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.10.5 Progenics Pharmaceuticals Recent Developments/Updates
6.11 International Isotopes
6.11.1 International Isotopes Corporation Information
6.11.2 International Isotopes Therapeutic Nuclear Medicines Description and Business Overview
6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
6.11.5 International Isotopes Recent Developments/Updates

7 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
7.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
7.4 Therapeutic Nuclear Medicines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Therapeutic Nuclear Medicines Distributors List
8.3 Therapeutic Nuclear Medicines Customers

9 Therapeutic Nuclear Medicines Market Dynamics
9.1 Therapeutic Nuclear Medicines Industry Trends
9.2 Therapeutic Nuclear Medicines Growth Drivers
9.3 Therapeutic Nuclear Medicines Market Challenges
9.4 Therapeutic Nuclear Medicines Market Restraints

10 Global Market Forecast
10.1 Therapeutic Nuclear Medicines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Type (2022-2027)
10.2 Therapeutic Nuclear Medicines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Application (2022-2027)
10.3 Therapeutic Nuclear Medicines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Therapeutic Nuclear Medicines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Therapeutic Nuclear Medicines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Therapeutic Nuclear Medicines Covered in This Study
Table 5. Global Therapeutic Nuclear Medicines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites and Area Served
Table 11. Manufacturers Therapeutic Nuclear Medicines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Therapeutic Nuclear Medicines Sales by Region (2016-2021) & (K Units)
Table 16. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)
Table 17. Global Therapeutic Nuclear Medicines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)
Table 19. North America Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)
Table 20. North America Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)
Table 22. Europe Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)
Table 24. Europe Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)
Table 32. Latin America Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)
Table 38. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2016-2021)
Table 39. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
Table 40. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Therapeutic Nuclear Medicines Revenue Share by Type (2016-2021)
Table 42. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2016-2021)
Table 43. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2016-2021)
Table 44. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
Table 45. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Therapeutic Nuclear Medicines Revenue Share by Application (2016-2021)
Table 47. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2016-2021)
Table 48. Novartis AG Corporation Information
Table 49. Novartis AG Description and Business Overview
Table 50. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novartis AG Therapeutic Nuclear Medicines Product
Table 52. Novartis AG Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Bayer Therapeutic Nuclear Medicines Product
Table 57. Bayer Recent Developments/Updates
Table 58. China Isotope & Radiation Corporation Information
Table 59. China Isotope & Radiation Description and Business Overview
Table 60. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. China Isotope & Radiation Therapeutic Nuclear Medicines Product
Table 62. China Isotope & Radiation Recent Developments/Updates
Table 63. Q BioMed Corporation Information
Table 64. Q BioMed Description and Business Overview
Table 65. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Q BioMed Therapeutic Nuclear Medicines Product
Table 67. Q BioMed Recent Developments/Updates
Table 68. Curium Pharmaceuticals Corporation Information
Table 69. Curium Pharmaceuticals Description and Business Overview
Table 70. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 72. Curium Pharmaceuticals Recent Developments/Updates
Table 73. Jubilant DraxImage Corporation Information
Table 74. Jubilant DraxImage Description and Business Overview
Table 75. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Jubilant DraxImage Therapeutic Nuclear Medicines Product
Table 77. Jubilant DraxImage Recent Developments/Updates
Table 78. Dongcheng Corporation Information
Table 79. Dongcheng Description and Business Overview
Table 80. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Dongcheng Therapeutic Nuclear Medicines Product
Table 82. Dongcheng Recent Developments/Updates
Table 83. Lantheus Corporation Information
Table 84. Lantheus Description and Business Overview
Table 85. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Lantheus Therapeutic Nuclear Medicines Product
Table 87. Lantheus Recent Developments/Updates
Table 88. Acrotech Biopharma. Corporation Information
Table 89. Acrotech Biopharma. Description and Business Overview
Table 90. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Acrotech Biopharma. Therapeutic Nuclear Medicines Product
Table 92. Acrotech Biopharma. Recent Developments/Updates
Table 93. Progenics Pharmaceuticals Corporation Information
Table 94. Progenics Pharmaceuticals Description and Business Overview
Table 95. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product
Table 97. Progenics Pharmaceuticals Recent Developments/Updates
Table 98. International Isotopes Corporation Information
Table 99. International Isotopes Description and Business Overview
Table 100. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. International Isotopes Therapeutic Nuclear Medicines Product
Table 102. International Isotopes Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Therapeutic Nuclear Medicines Distributors List
Table 106. Therapeutic Nuclear Medicines Customers List
Table 107. Therapeutic Nuclear Medicines Market Trends
Table 108. Therapeutic Nuclear Medicines Growth Drivers
Table 109. Therapeutic Nuclear Medicines Market Challenges
Table 110. Therapeutic Nuclear Medicines Market Restraints
Table 111. Global Therapeutic Nuclear Medicines Sales Forecast by Type (2022-2027) & (K Units)
Table 112. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2022-2027)
Table 113. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 114. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2022-2027)
Table 115. Global Therapeutic Nuclear Medicines Sales Forecast by Application (2022-2027) & (K Units)
Table 116. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2022-2027)
Table 117. Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 118. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Application (2022-2027)
Table 119. Global Therapeutic Nuclear Medicines Sales Forecast by Region (2022-2027) & (K Units)
Table 120. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2022-2027)
Table 121. Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 122. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2022-2027)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic Nuclear Medicines
Figure 2. Global Therapeutic Nuclear Medicines Market Share by Type in 2020 & 2027
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Nuclear Medicines Market Share by Application in 2020 & 2027
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Therapeutic Nuclear Medicines Market Size 2016-2027 (US$ Million)
Figure 14. Global Therapeutic Nuclear Medicines Sales 2016-2027 (K Units)
Figure 15. Global Therapeutic Nuclear Medicines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2020
Figure 17. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Therapeutic Nuclear Medicines Players: Market Share by Revenue in 2020
Figure 19. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)
Figure 21. Global Therapeutic Nuclear Medicines Sales Market Share by Region in 2020
Figure 22. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2021)
Figure 23. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2020
Figure 24. U.S. Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Therapeutic Nuclear Medicines by Type (2016-2021)
Figure 49. Sales Market Share of Therapeutic Nuclear Medicines by Application (2016-2021)
Figure 50. Sales Market Share of Therapeutic Nuclear Medicines by Application in 2020
Figure 51. Revenue Share of Therapeutic Nuclear Medicines by Application (2016-2021)
Figure 52. Revenue Share of Therapeutic Nuclear Medicines by Application in 2020
Figure 53. Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure 54. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 55. Therapeutic Nuclear Medicines Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed